Search Clinical Trials
Sponsor Condition of Interest |
---|
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell...
North American Consortium for Histiocytosis
Langerhans Cell Histiocytosis
The LCH-IV is an international, multicenter, prospective clinical study for pediatric
Langerhans Cell Histiocytosis LCH (age < 18 years). expand
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years). Type: Interventional Start Date: Nov 2016 |
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS...
Carelon Research
Congenital Heart Disease in Children
COMPASS is a prospective multicenter randomized interventional trial. Participants with
ductal-dependent pulmonary blood flow will be randomized to receive either a
systemic-to-pulmonary artery shunt or ductal artery stent. Block randomization will be
performed by center and by single vs. two ventricle... expand
COMPASS is a prospective multicenter randomized interventional trial. Participants with ductal-dependent pulmonary blood flow will be randomized to receive either a systemic-to-pulmonary artery shunt or ductal artery stent. Block randomization will be performed by center and by single vs. two ventricle status. Participants will be followed through the first year of life. Type: Interventional Start Date: Jun 2022 |
GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS
Nationwide Children's Hospital
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome
The GRACE-2 study is a prospective, multi-center, double-blind, randomized controlled
trial of the drug GM-CSF vs placebo in children with sepsis-induced multiple organ
dysfunction syndrome (MODS) who have immunoparalysis with mild to moderate inflammation. expand
The GRACE-2 study is a prospective, multi-center, double-blind, randomized controlled trial of the drug GM-CSF vs placebo in children with sepsis-induced multiple organ dysfunction syndrome (MODS) who have immunoparalysis with mild to moderate inflammation. Type: Interventional Start Date: Jun 2022 |
Technology-Enhanced Executive Functioning Intervention for ADHD
Children's National Research Institute
ADHD
Attention Deficit Hyperactivity Disorder
Attention Deficit Disorder
ADD
ADHD Predominantly Inattentive Type
This study develops and refines an online platform that will support clinician-directed
behavioral and organizational skills intervention for adolescents with
Attention-Deficit/Hyperactivity Disorder (ADHD) with input guided from key stakeholders
during focus groups and interviews (phase 1), extended... expand
This study develops and refines an online platform that will support clinician-directed behavioral and organizational skills intervention for adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) with input guided from key stakeholders during focus groups and interviews (phase 1), extended usability testing (phase 2), and a pilot randomized trial (phase 3) of the online tool used in conjunction with an organizational skills intervention. Type: Interventional Start Date: Feb 2021 |
Digital Dysmorphology Project
Kevin Cleary
Down Syndrome
In this study, the investigators propose a novel method to detect Down syndrome using
photography for facial dysmorphology, a tool called computer-aided diagnosis (CAD). After
validating the method, this technology will be expanded to perform similar functions to
assist in the detection of other dysmorphic... expand
In this study, the investigators propose a novel method to detect Down syndrome using photography for facial dysmorphology, a tool called computer-aided diagnosis (CAD). After validating the method, this technology will be expanded to perform similar functions to assist in the detection of other dysmorphic syndromes. By using photography and image analysis this automated assessment tool would have the potential to improve the diagnosis rate and allow for remote, non-invasive diagnostic evaluation for dysmorphologists in a timely manner. Type: Interventional Start Date: Feb 2013 |
EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study
Berlin Heart, Inc
Heart Failure
Transplant; Failure, Heart
Congenital Heart Disease
The purpose of this study is to evaluate the device performance and monitor the safety
and effectiveness of the Berlin Heart EXCOR Active Driving System while being used with
the approved EXCOR Pediatric Ventricular Assist Device.
EXCOR Active Driving System is intended for use with the approved... expand
The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Driving System while being used with the approved EXCOR Pediatric Ventricular Assist Device. EXCOR Active Driving System is intended for use with the approved EXCOR Pediatric VAD. The EXCOR Pediatric VAD is intended to provide mechanical circulatory support as a bridge to cardiac transplantation for pediatric patients. Pediatric candidates with severe isolated left ventricular or biventricular dysfunction who are candidates for cardiac transplant and require circulatory support may be treated using the EXCOR Pediatric. EXCOR Active is intended for use in a clinical setting. EXCOR Active can be used in any kind of hospital unit (e.g. OR, ICU, intermediate care unit or general care unit). The driving unit may be moved between clinical units using the caddy or baby buggy; however, a patient must always be accompanied by a person trained in the use of the manual pump and emergency procedures during transport in the event of an emergency. The driving unit can be transported during operation. Type: Interventional Start Date: Nov 2022 |
- Previous
- Next